14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $11.01 $14.21 Friday, 3rd May 2024 IOVA stock ended at $13.63. This is 5.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $13.30 to a day high of $13.88.
90 days $7.62 $18.33
52 weeks $3.21 $18.33

Historical Iovance Biotherapeutics, Inc. prices

Date Open High Low Close Volume
Jul 19, 2023 $8.20 $8.26 $7.75 $7.80 4 096 914
Jul 18, 2023 $8.00 $8.29 $8.00 $8.15 4 318 036
Jul 17, 2023 $7.82 $8.09 $7.55 $8.02 6 665 733
Jul 14, 2023 $7.84 $7.82 $7.44 $7.76 4 632 928
Jul 13, 2023 $7.88 $7.88 $7.37 $7.68 8 026 831
Jul 12, 2023 $8.10 $8.10 $7.77 $7.87 6 193 012
Jul 11, 2023 $7.82 $8.17 $7.70 $7.93 20 028 884
Jul 10, 2023 $7.29 $8.81 $7.29 $8.79 14 916 273
Jul 07, 2023 $6.80 $7.28 $6.80 $7.24 5 776 115
Jul 06, 2023 $6.98 $7.02 $6.80 $6.81 3 276 962
Jul 05, 2023 $7.10 $7.15 $6.99 $7.06 2 174 962
Jul 03, 2023 $7.06 $7.17 $7.01 $7.10 1 645 966
Jun 30, 2023 $7.12 $7.22 $6.94 $7.04 3 062 800
Jun 29, 2023 $7.32 $7.39 $7.00 $7.05 3 926 379
Jun 28, 2023 $7.54 $7.58 $7.35 $7.38 4 525 611
Jun 27, 2023 $7.63 $7.70 $7.30 $7.55 3 431 702
Jun 26, 2023 $8.09 $8.08 $7.52 $7.53 4 675 812
Jun 23, 2023 $7.95 $8.14 $7.98 $8.07 9 626 745
Jun 22, 2023 $8.18 $8.31 $8.10 $8.12 2 351 485
Jun 21, 2023 $8.26 $8.37 $7.94 $8.24 4 475 492
Jun 20, 2023 $8.02 $8.35 $7.83 $8.28 6 101 114
Jun 16, 2023 $8.77 $8.77 $8.06 $8.12 11 097 811
Jun 15, 2023 $8.59 $8.82 $8.52 $8.64 5 936 030
Jun 14, 2023 $8.88 $8.86 $8.43 $8.67 5 410 561
Jun 13, 2023 $8.57 $8.91 $8.53 $8.84 5 500 177
Click to get the best stock tips daily for free!

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics. Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers... IOVA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT